Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001493152-24-005335
Filing Date
2024-02-07
Accepted
2024-02-07 18:55:18
Documents
1

Document Format Files

Seq Description Document Type Size
1 formsc13ga.htm SC 13G/A 89972
  Complete submission text file 0001493152-24-005335.txt   91283
Mailing Address 101 EAST 52ND ST NEW YORK NY 10022
Business Address
HIRSCHMAN ORIN (Filed by) CIK: 0001131362 (see all company filings)

Type: SC 13G/A

Mailing Address 25 BURLINGTON MALL ROAD, SUITE 203 BURLINGTON MA 01803
Business Address 25 BURLINGTON MALL ROAD, SUITE 203 BURLINGTON MA 01803 617-517-0730
scPharmaceuticals Inc. (Subject) CIK: 0001604950 (see all company filings)

EIN.: 465184075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90193 | Film No.: 24606314
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)